Owens & Minor (NYSE:OMI) PT Lowered to $24.00 at Robert W. Baird

Owens & Minor (NYSE:OMI) had its price objective reduced by Robert W. Baird from $28.00 to $24.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have a neutral rating on the stock.

Other equities analysts have also recently issued reports about the stock. Citigroup upped their price target on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a neutral rating in a research note on Tuesday, April 30th. UBS Group dropped their target price on shares of Owens & Minor from $28.00 to $26.00 and set a buy rating for the company in a report on Monday, January 29th. SVB Leerink initiated coverage on Owens & Minor in a research note on Monday, February 26th. They set a market perform rating and a $24.00 price target on the stock. Barclays upped their price target on Owens & Minor from $21.00 to $23.00 and gave the stock an equal weight rating in a report on Wednesday, February 21st. Finally, StockNews.com upgraded Owens & Minor from a hold rating to a buy rating in a research report on Wednesday, February 21st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Hold and a consensus price target of $23.29.

Owens & Minor Trading Down 4.2 %

NYSE OMI opened at $18.12 on Monday. The company has a quick ratio of 0.56, a current ratio of 1.16 and a debt-to-equity ratio of 2.17. The stock has a market capitalization of $1.39 billion, a P/E ratio of -35.53, a P/E/G ratio of 0.57 and a beta of 0.52. Owens & Minor has a 52-week low of $13.64 and a 52-week high of $28.35. The firm has a 50-day moving average price of $25.00 and a 200 day moving average price of $21.53.

Owens & Minor (NYSE:OMI) last issued its earnings results on Friday, May 3rd. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The business had revenue of $2.61 billion during the quarter, compared to the consensus estimate of $2.61 billion. During the same period in the prior year, the business posted $0.05 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Equities research analysts expect that Owens & Minor will post 1.54 EPS for the current year.

Insider Activity at Owens & Minor

In related news, SVP Michael Wayne Lowry sold 10,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of Owens & Minor stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jonathan A. Leon sold 5,000 shares of the stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the transaction, the senior vice president now directly owns 84,673 shares in the company, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. Corporate insiders own 2.62% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of OMI. Riverview Trust Co purchased a new stake in Owens & Minor in the first quarter valued at approximately $25,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of Owens & Minor during the 3rd quarter valued at $29,000. Quest Partners LLC acquired a new stake in shares of Owens & Minor during the 4th quarter worth $41,000. Hexagon Capital Partners LLC raised its position in shares of Owens & Minor by 1,240.2% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock worth $43,000 after buying an additional 1,451 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Owens & Minor by 52.1% in the first quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock valued at $46,000 after acquiring an additional 563 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.